All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the International Myeloma Foundation or Myeloma crowd.

The Multiple Myeloma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

LUMMICAR STUDY 2

(NCT03915184)

LUMMICAR STUDY 2

(NCT03915184)

Clinical Trial to Evaluate CT053 in Patients With Relapsed and/or Refractory Multiple Myeloma
|||